Danaher Corporation $DHR Stock Sold by Sustainable Growth Advisers LP

Key Points

• Sustainable Growth Advisers LP cut its Danaher position by 28.4% in the third quarter, selling 421,516 shares and retaining 1.06 million shares worth approximately $235.7 million. Institutional investors still own about 79.1% of Danaher.
• Analysts remain broadly bullish, with a consensus “Moderate Buy” rating and an average price target of $235.41; several firms recently raised their targets to between $240 and $255.
• Danaher shares opened at $231.52 after rising 3%, while the company reported quarterly EPS and revenue above expectations and announced a $0.40-per-share quarterly dividend.

Sustainable Growth Advisers LP lowered its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 28.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,063,782 shares of the conglomerate's stock after selling 421,516 shares during the quarter. Danaher makes up about 2.6% of Sustainable Growth Advisers LP's holdings, making the stock its 15th largest holding. Sustainable Growth Advisers LP owned 0.15% of Danaher worth $235,681,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in DHR. Patriot Investment Management Group Inc. acquired a new position in Danaher in the 3rd quarter valued at $944,000. NFSG Corp boosted its stake in Danaher by 488.8% during the 3rd quarter. NFSG Corp now owns 3,091 shares of the conglomerate's stock worth $685,000 after purchasing an additional 2,566 shares during the last quarter. Detalus Advisors LLC grew its holdings in shares of Danaher by 975.1% during the third quarter. Detalus Advisors LLC now owns 12,708 shares of the conglomerate's stock worth $2,815,000 after buying an additional 11,526 shares in the last quarter. Murphy Middleton Hinkle & Parker Inc. acquired a new stake in shares of Danaher in the third quarter valued at about $6,985,000. Finally, Walser Wealth Management Company A Ltd Liability Co purchased a new position in shares of Danaher in the third quarter worth about $1,459,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Barclays boosted their price target on shares of Danaher from $230.00 to $255.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 7th. Evercore reaffirmed an "outperform" rating and issued a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. Morgan Stanley raised their target price on Danaher from $220.00 to $240.00 and gave the stock an "overweight" rating in a research note on Monday. Finally, Royal Bank Of Canada upped their price target on Danaher from $215.00 to $250.00 and gave the company an "outperform" rating in a research note on Monday, October 5th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, Danaher currently has a consensus rating of "Moderate Buy" and a consensus price target of $235.41.

Danaher Trading Up 3.0%

Shares of DHR stock opened at $231.52 on Friday. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The firm has a market cap of $162.76 billion, a PE ratio of 41.12, a price-to-earnings-growth ratio of 2.82 and a beta of 0.76. The company has a 50-day moving average of $213.55 and a two-hundred day moving average of $195.74. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business's revenue was up 5.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.77 EPS. On average, analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher's dividend payout ratio (DPR) is presently 28.42%.

Key Stories Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher and NVIDIA announced an AI collaboration to combine Danaher’s scientific instruments, laboratory workflows, automation technology and software with NVIDIA’s accelerated computing and AI capabilities. The partnership is intended to advance autonomous science and speed drug discovery and other laboratory research. Danaher Collaborates with NVIDIA to Advance Autonomous Science
• Positive Sentiment: Danaher is also preparing to launch its first AI-powered autonomous laboratory, targeted to operate at commercial scale in early 2027. The initiative could support longer-term growth in laboratory automation and strengthen the company’s position in AI-enabled life-science research. How to Invest in AI Drug Discovery
• Positive Sentiment: Multiple Zacks reports say Danaher has a favorable combination of earnings-estimate trends and Earnings ESP, suggesting potential for the company to exceed consensus estimates in its next quarterly report. Danaher has also recently demonstrated earnings momentum, with its latest reported quarter exceeding both EPS and revenue expectations. Will Danaher Beat Estimates Again in Its Next Earnings Report?
• Neutral Sentiment: Danaher is projected to announce earnings on Wednesday. Investors will be watching revenue growth, management’s outlook and whether diagnostics and life-sciences demand support the anticipated improvement in earnings. Danaher Projected to Announce Earnings

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.